| oxidation reduction process | GO:0055114 | 342 | 0.797 | |
| coenzyme metabolic process | GO:0006732 | 52 | 0.616 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.503 | |
| cofactor catabolic process | GO:0051187 | 6 | 0.498 | |
| nucleoside bisphosphate metabolic process | GO:0033865 | 9 | 0.496 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.429 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.368 | |
| coenzyme a metabolic process | GO:0015936 | 8 | 0.338 | |
| coenzyme catabolic process | GO:0009109 | 5 | 0.289 | |
| coenzyme biosynthetic process | GO:0009108 | 23 | 0.202 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.197 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.190 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.189 | |
| amine metabolic process | GO:0009308 | 45 | 0.160 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.150 | |
| thioester metabolic process | GO:0035383 | 19 | 0.138 | |
| acetyl coa metabolic process | GO:0006084 | 8 | 0.135 | |
| ribonucleoside bisphosphate metabolic process | GO:0033875 | 9 | 0.126 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.122 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.119 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.109 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.102 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.100 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.096 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.092 | |
| neuronal action potential | GO:0019228 | 54 | 0.086 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.086 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.082 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.082 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.072 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.058 | |
| response to catecholamine | GO:0071869 | 4 | 0.053 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.053 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.051 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.051 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.047 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.046 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.043 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.043 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.043 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.043 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.042 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.041 | |
| positive regulation of oocyte development | GO:0060282 | 4 | 0.041 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.041 | |
| maintenance of location | GO:0051235 | 89 | 0.040 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.040 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.039 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.039 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.038 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.037 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.037 | |
| acyl coa metabolic process | GO:0006637 | 19 | 0.035 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.035 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.033 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.032 | |
| attachment of spindle microtubules to kinetochore | GO:0008608 | 4 | 0.032 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.032 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.031 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.031 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.030 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.030 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.030 | |
| very long chain fatty acid catabolic process | GO:0042760 | 2 | 0.029 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.029 | |
| fatty acid oxidation | GO:0019395 | 28 | 0.029 | |
| regulation of defense response to bacterium | GO:1900424 | 3 | 0.028 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.028 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.027 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.026 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.026 | |
| insulin secretion | GO:0030073 | 89 | 0.026 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.026 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.025 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.025 | |
| cellular respiration | GO:0045333 | 38 | 0.025 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.025 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.024 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.024 | |
| action potential | GO:0001508 | 78 | 0.024 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.024 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.024 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.023 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.023 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.023 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.022 | |
| positive regulation of chromosome segregation | GO:0051984 | 4 | 0.022 | |
| positive regulation of oocyte maturation | GO:1900195 | 2 | 0.022 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.022 | |
| urogenital system development | GO:0001655 | 261 | 0.021 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.021 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.021 | |
| response to nutrient levels | GO:0031667 | 109 | 0.021 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.021 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.021 | |
| response to starvation | GO:0042594 | 65 | 0.021 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.021 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.020 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.020 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.020 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.020 | |
| muscle tissue development | GO:0060537 | 308 | 0.020 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.019 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.019 | |
| rhythmic process | GO:0048511 | 174 | 0.019 | |
| cation transport | GO:0006812 | 399 | 0.019 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.019 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.019 | |
| regulation of protein localization | GO:0032880 | 231 | 0.018 | |
| regulation of binding | GO:0051098 | 111 | 0.018 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.018 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.018 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.018 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.018 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.018 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.018 | |
| nuclear division | GO:0000280 | 158 | 0.018 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.017 | |
| regulation of nlrp3 inflammasome complex assembly | GO:1900225 | 4 | 0.017 | |
| alpha amino acid catabolic process | GO:1901606 | 18 | 0.017 | |
| camera type eye development | GO:0043010 | 266 | 0.017 | |
| lipid oxidation | GO:0034440 | 29 | 0.017 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.017 | |
| chromatin modification | GO:0016568 | 187 | 0.017 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.016 | |
| schwann cell differentiation | GO:0014037 | 26 | 0.016 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.016 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.016 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.016 | |
| gland development | GO:0048732 | 330 | 0.016 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.016 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.016 | |
| response to steroid hormone | GO:0048545 | 56 | 0.016 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.016 | |
| peptide secretion | GO:0002790 | 114 | 0.016 | |
| lipid catabolic process | GO:0016042 | 69 | 0.016 | |
| amide transport | GO:0042886 | 138 | 0.016 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.016 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.016 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.015 | |
| protein tetramerization | GO:0051262 | 23 | 0.015 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.015 | |
| cellular amino acid biosynthetic process | GO:0008652 | 22 | 0.015 | |
| cellular response to lipid | GO:0071396 | 145 | 0.015 | |
| chromatin organization | GO:0006325 | 206 | 0.015 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.015 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.015 | |
| myelination | GO:0042552 | 74 | 0.015 | |
| protein oligomerization | GO:0051259 | 67 | 0.015 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.015 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.015 | |
| glial cell development | GO:0021782 | 54 | 0.014 | |
| fat cell differentiation | GO:0045444 | 160 | 0.014 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.014 | |
| quinone metabolic process | GO:1901661 | 7 | 0.014 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.014 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 56 | 0.014 | |
| hormone metabolic process | GO:0042445 | 86 | 0.014 | |
| histone modification | GO:0016570 | 159 | 0.014 | |
| lipid localization | GO:0010876 | 126 | 0.014 | |
| lateral inhibition | GO:0046331 | 1 | 0.014 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.014 | |
| myelination in peripheral nervous system | GO:0022011 | 19 | 0.014 | |
| glial cell differentiation | GO:0010001 | 131 | 0.014 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.014 | |
| tissue homeostasis | GO:0001894 | 115 | 0.013 | |
| chemotaxis | GO:0006935 | 247 | 0.013 | |
| transmembrane transport | GO:0055085 | 412 | 0.013 | |
| developmental maturation | GO:0021700 | 193 | 0.013 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.013 | |
| axon ensheathment | GO:0008366 | 76 | 0.013 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.013 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.013 | |
| cofactor biosynthetic process | GO:0051188 | 41 | 0.013 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.013 | |
| digestive system development | GO:0055123 | 200 | 0.013 | |
| cytokine production | GO:0001816 | 319 | 0.013 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.013 | |
| substantia nigra development | GO:0021762 | 2 | 0.013 | |
| epithelial cell development | GO:0002064 | 159 | 0.013 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.013 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.013 | |
| regulation of secretion | GO:0051046 | 274 | 0.013 | |
| digestive tract development | GO:0048565 | 190 | 0.013 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.013 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.013 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.013 | |
| protein catabolic process | GO:0030163 | 221 | 0.013 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.012 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.012 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.012 | |
| regulation of attachment of spindle microtubules to kinetochore | GO:0051988 | 3 | 0.012 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.012 | |
| microtubule based process | GO:0007017 | 236 | 0.012 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.012 | |
| protein deacetylation | GO:0006476 | 32 | 0.012 | |
| gliogenesis | GO:0042063 | 141 | 0.012 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.012 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.012 | |
| axon guidance | GO:0007411 | 141 | 0.011 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.011 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.011 | |
| intracellular protein transport | GO:0006886 | 204 | 0.011 | |
| placenta development | GO:0001890 | 140 | 0.011 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.011 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.011 | |
| connective tissue development | GO:0061448 | 179 | 0.011 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.011 | |
| regulation of myelination | GO:0031641 | 20 | 0.011 | |
| ketone catabolic process | GO:0042182 | 3 | 0.011 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.011 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.011 | |
| regulation of t helper 2 cell cytokine production | GO:2000551 | 3 | 0.011 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.011 | |
| renal system development | GO:0072001 | 225 | 0.011 | |
| oxidoreduction coenzyme metabolic process | GO:0006733 | 16 | 0.011 | |
| sensory perception | GO:0007600 | 245 | 0.011 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.011 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.011 | |
| response to acid chemical | GO:0001101 | 111 | 0.011 | |
| response to oxidative stress | GO:0006979 | 123 | 0.011 | |
| muscle system process | GO:0003012 | 141 | 0.010 | |
| histone h3 deacetylation | GO:0070932 | 8 | 0.010 | |
| lipid modification | GO:0030258 | 65 | 0.010 | |
| mitochondrial electron transport nadh to ubiquinone | GO:0006120 | 4 | 0.010 | |
| regulation of response to drug | GO:2001023 | 2 | 0.010 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.010 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.010 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.010 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.010 | |
| embryonic placenta development | GO:0001892 | 98 | 0.010 | |
| peptidyl lysine deacetylation | GO:0034983 | 1 | 0.010 | |
